Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-01-09
2007-01-09
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S161000
Reexamination Certificate
active
10524960
ABSTRACT:
The present invention provides crystalline biphenyl-4-carboxylic acid (R)-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2(R)-hydroxyindan-1-yl)amide hemihydrate, compositions thereof, methods of using the same, processes for making the same, and processes for making intermediates thereof.
REFERENCES:
patent: 2004/0242584 (2004-12-01), Allen et al.
patent: WO 03/027061 (2003-04-01), None
Shannon et al. “Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice” Schizophrenia Research 2000, vol. 42, pp. 249-259.
Bush Julie Kay
Heath Perry Clark
Eli Lilly and Company
Hostettler Danica
Kosack Joseph R.
McKane Joseph K.
Tucker Tina M.
LandOfFree
Hemihydrate of a selective functional M1 muscarine receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemihydrate of a selective functional M1 muscarine receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemihydrate of a selective functional M1 muscarine receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760820